跳至主要内容
临床试验/NCT04947852
NCT04947852已完成不适用

Efficacy of NIV Masks in COPD Patients With Chronic Respiratory Failure: A Randomized Controlled Cross Over Pilot

Fisher and Paykel Healthcare2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2021年7月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
试验地点
2
主要终点
Transcutaneous Carbon Dioxide

研究概览

简要总结

A randomized controlled pilot study to compare the efficacy and tolerability of a two different NIV masks on carbon dioxide in participants with stable chronic obstructive pulmonary disease (COPD) with chronic type II respiratory failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A doctor's diagnosis of COPD
  • PtCO2 ≥45mmHg on transcutaneous monitor at baseline measure
  • Oxygen saturation measured by pulse oximetry (SpO2) ≥85%
  • Fits the study mask
  • Can tolerate the therapy

排除标准

  • FEV1/FVC ≥70%
  • Body mass index >35
  • Hypercapnia considered to be primarily due to Obesity Hypoventilation syndrome and/or Obstructive Sleep Apnea
  • Any condition which makes NIV contra-indicated as per BTS guidelines based on clinical judgement

结局指标

主要结局

Transcutaneous Carbon Dioxide

时间窗: 60 minutes

mmHg

次要结局

  • Minute Ventilation(60 minutes)
  • Respiratory Rate(60 minutes)
  • Oxygen Saturation(60 minutes)
  • Heart Rate(60 minutes)
  • Borg Dyspnoea Score(60 Minutes)

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Efficacy of NIV Masks in COPD | 临床试验